Replies to post #72327 on PharmaCyte Biotech Inc (PMCB)

[$Pistol Pete$]

$PMCB http://tuckermantimes.com/pharmacyte-biotech-inc-pmcb-close-higher-than-psar-line/254046/
PharmaCyte Biotech Inc (PMCB) Close Higher Than PSAR Line
The Times - 1d ago


Shares of PharmaCyte Biotech Inc (PMCB) are on watch as they closed the most recent session above the Parabolic SAR line. The current level of the shares currently stands at 0.0820 at the time of writing.

[JimboPMCB]

Tell me an OTC that doesn't have red flags?

[1234jklm]

What percentage of outgoings was that?

[1234jklm]

show us the shares.Concordia?

PHARMACYTE BIOTECH, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
YEARS ENDED APRIL 30, 2017 AND 2016

Common stock Paid in Common
Stock Accumulated Accumulated
Other
Comprehensive Total
Stockholders’

Shares Amount Capital to be issued Deficit Income Equity

Balance, April 30, 2015, as restated 732,760,536 $ 73,273 $ 86,330,224 $ – $ (78,627,833 ) $ 1,462 $ 7,777,126

Shares issued for compensation 4,800,000 480 404,600 – – – 405,080
Shares issued for services 750,000 75 47,925 – – – 48,000
Shares issued for cash 42,922,802 4,299 3,563,851 – – – 3,568,150
Stock options granted – – 788,770 – – – 788,770
Foreign currency translation adjustment – – – – – (656 ) (656 )
Net loss – – – – (6,063,784 ) – (6,063,784 )
Balance, April 30, 2016 781,233,338 78,127 91,135,370 – (84,691,617 ) 806 6,522,686

Shares issued for compensation 6,600,000 660 419,820 – – – 420,480
Shares issued for services 2,100,000 210 107,290 – – – 107,500
Shares issued for cash, net of issuance costs of $152,250 115,415,709 11,537 4,870,399 – – – 4,881,936
Stock options granted – – 597,400 – – – 597,400
Foreign currency translation adjustment – – – – – 930 930
Net loss – – – – (4,443,685 ) – (4,443,685 )
Balance, April 30, 2017 905,349,047 $ 90,534